Myron S. Cohen
Myron S. Cohen | |
|---|---|
| Born | Myron Scott Cohen 7 May 1950 |
| Nationality | American |
| Alma mater | University of Illinois Urbana-Champaign Rush Medical College University of Michigan Yale University |
| Known for | HIV Prevention Trials Network 052 study |
| Scientific career | |
| Fields | HIV, Medicine, Epidemiology |
| Institutions | University of North Carolina at Chapel Hill HIV Prevention Trials Network |
| Doctoral students | Kimberly Powers |
Myron Scott Cohen (born May 7, 1950 in Chicago, Illinois) is an American physician-scientist who has made substantial contributions to our understanding of the transmission prevention of transmission of HIV. He is best known as chief architect of HIV Prevention Trials Network 052, a large-scale randomized clinical trial which demonstrated proof-of-concept for “treatment as prevention”: treating an HIV-infected person with antiviral drugs makes them less contagious and prevents transmission to their sexual partners. Cohen is J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology at the University of North Carolina at Chapel Hill. He is also co-chair of the National Institutes of Health's HIV Prevention Trials Network.